CT-721

• Target :

  Others|||Bcr-Abl

• Related Pathways :

  Cytoskeletal Signaling|||Others|||Angiogenesis|||Tyrosine Kinase/Adaptors

• Bioactivity :

  CT-721 is a potent, time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase, exhibiting anti-chronic myeloid leukemia (CML) activity.

• Smiles :

  C(NC1=CC(C#CC=2N3C(=NC2)C=CC(Cl)=N3)=C(C)C=C1)(=O)C=4C=C5C([C@H](CC5)N6CCN(C)CC6)=CC4

• Molecular Formula :

  C30H29ClN6O

• Molecular Weight :

  525.04

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1388710-60-8